west virginia semaglutide side effect law office lawyer in How WV plans to spend $1 billion in opioid settlements west virginia semaglutide nausea – glp-1 gastroparesis lawsuit in west – glp-1 gastric stasis class action

Who Qualifies Standard eligibility for semaglutide-based weight loss treatment follows the criteria used in clinical trials and FDA labeling: a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia

T2DM patients exhibit a 3-fold higher susceptibility to tuberculosis, directly reflecting measurable functional failure of NK cells and T cells

Medically supervised weight loss programs and the associated prescription medications are typically qualified medical expenses

So semaglutides slimming of body fat does seem to help explain why it prevents heart diseasebut only partly